Showing items 1 - 7 of 7

Your selections:

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

The contribution of methamphetamine use to crime: evidence from Australian longitudinal data

Latent psychotic symptom profiles amongst people who use methamphetamine: what do they tell us about existing diagnostic categories?

Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users

Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)

Ensuring the safety of new medications and devices: are naltrexone implants safe? (editorial)

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit